Sanford-Burnham News Archive

John Reed, M.D., Ph.D, President and CEO of the Burnham Institute for Medical Research, Rings the NASDAQ Opening Bell

, March 20, 2008

March 20, 2008 - Burnham Institute for Medical Research rang the opening bell for NASDAQ on Thursday, March 20 at 6:30 a.m. PDST/9:30 a.m. EDST. The event was a celebration in recognition of the establishment of Burnham’s bicoastal operations. Pictures from the event can be viewed on the NASDAQ website.

Joining Burnham president and CEO John Reed was a delegation of twenty-two representatives, including Burnham board of trustee’s vice chairman Greg Lucier, who is chairman and CEO of Invitrogen; and Burnham supporters with a collective representation on the boards of directors of 11 NASDAQ-Listed companies.

Burnham’s Florida organization was represented by Orange County Mayor Richard Crotty, Burnham board of trustees member Robert Mandell; Anne Chinoda, CEO of Florida’s Blood Centers; Jim Zboril of Lake Nona; and other community supporters.

The full delegation included:

Ted Bonanno
Attorney, Heller Ehrman LLP
Governor Bush’s staff during transaction

Kay Chandler
Partner, Cooley Godward Kronish
Counsel to Burnham for Florida transaction

Anne Chinoda
President and CEO, Florida’s Blood Centers
Home of Burnham’s temporary facility

Howard Cohen
Burnham Trustee

Mayor Richard Crotty
Orange County, Florida

Nicole DeBerg-Nelson
CFO and Vice President of Finance, Burnham Institute for Medical Research

Karin Eastham
Executive Vice President and COO, Burnham Institute for Medical Research
Burnham Trustee

M. Wainwright Fishburn
Partner, Cooley Godward Kronish
Former Burnham Trustee

Elizabeth Gianini
Vice President, External Relations, Burnham at Lake Nona, Orlando

Alan Gleicher
Gleicher Capital, LLC
Burnham Trustee

Michael Grindstaff
Partner, Shutts & Bowen
Represented Burnham on Florida transaction

David Hale
Chairman, Hale BioPharma Ventures
Burnham Trustee

Brent Jacobs
Senior Vice President, Burnham Real Estate Services’ Life Science Group
Burnham Trustee

Greg Lucier
Chairman & CEO, Invitrogen
Burnham Trustee

Robert Mandell
Burnham Trustee

Andrea Moser
Vice President, Communications, Burnham Institute for Medical Research

Douglas Obenshain
Partner, Ernst & Young LLP, San Diego
Burnham Trustee

John C. Reed, M.D., Ph.D.
President and CEO, Burnham Institute for Medical Research
Burnham Trustee

Raquel Rodriguez
Partner, McDermott Will & Emery LLP
Governor Bush’s staff during transaction

Jennifer Tobin
Partner, Shutts & Bowen
Represented Burnham on Florida transaction

Jan Tuttleman, Ph.D., MBA
Vice President, Marketing, HUYA Bioscience International in San Diego
Burnham Trustee

Kenneth Woolcott
Principal, Six Degrees Capital Consulting
Burnham Trustee

James Zboril
President, Lake Nona
Lake Nona site of Burnham’s permanent home in Orlando

About Sanford-Burnham Medical Research Institute

Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham takes a collaborative approach to medical research with major programs in cancer, neurodegeneration and stem cells, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is recognized for its National Cancer Institute-designated Cancer Center and expertise in drug discovery technologies. Sanford-Burnham is a nonprofit, independent institute that employs more than 1,000 scientists and staff in San Diego (La Jolla), Calif., and Orlando (Lake Nona), Fla. For more information, visit us at

Sanford-Burnham can also be found on Facebook at and on Twitter @sanfordburnham.

News & News and Press - Sanford-Burnham Boilerplate
Sign In Skip Navigation Links Skip navigation links
News Archive
Sanford-Burnham In The News
Media Contacts and Guidelines
News Search
Paper of the Week
Quarterly Science Highlights
Multimedia Resources